LINDAHL RICHARD S 4

What Happened
Richard S. Lindahl, Chief Financial Officer of Emergent BioSolutions (EBS), had 683 shares of common stock withheld to satisfy tax withholding related to the vesting/settlement of restricted stock units. The withholding was treated as a disposition of 683 shares at $8.15 per share for a total value of $5,566 (transaction dated 2026-03-01; filing accession 0001196632-26-000006).

Key Details

• Transaction date and price: 2026-03-01 — 683 shares at $8.15/share (total $5,566).
• Transaction code: F (shares withheld to cover tax liability).
• Footnote: F1 — shares withheld to pay taxes associated with vesting and settlement of restricted stock units.
• Shares owned after transaction: not disclosed in the provided filing excerpt.
• Filing date: Form 4 filed with the SEC on 2026-03-03 (no indication the filing was late).

Context
This was a tax-withholding disposition tied to RSU settlement (a routine, administrative transaction), not an open-market sale intended to transfer economic exposure. Such withholdings are common when equity awards vest and do not necessarily signal insider sentiment about the company's stock. Retail investors typically pay more attention to outright open-market purchases and sales or changes in ownership trends over time.